The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au
Month: February 2026
Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS
The post Latest trial results show BTK inhibitor fenebrutinib effective in primary progressive MS appeared first on MS Australia. Source: www.msaustralia.org.au
My psychiatrist had some deep thoughts today
I have monthly appointments with a psychiatrist where I mainly discuss my experience with sleep medications that he prescribes for me. You see, I struggle with serial insomnia hence the regular appointments with the shrink. In the course of our meeting, we talk about lots of things including my experience with daily living. I admitted…
New MS initiative gives patients a stronger voice in research priorities
The Accelerated Cure Project for Multiple Sclerosis (ACP) has launched a new community-led initiative designed to ensure that people from underrepresented multiple sclerosis (MS) communities help set priorities for future MS research. sp The initiative, called Prioritized Research Agenda Development and Advancement (PRADA), creates a structured, collaborative process through which people living with MS can…
New real-world study supports long-term Ocrevus use in relapsing MS
In real-world clinical practice, Ocrevus (ocrelizumab) showed sustained effectiveness in people with relapsing forms of multiple sclerosis (MS), with most patients remaining free from long-term worsening of disability over four years, according to a new study. Relapse rates and MRI disease activity were also low during follow-up. At four years, 39.7% of patients with available…
Is riding a bus bad for your health?
Tweet Now the title of this post seemingly has nothing to do with the content of the paper, but what this new paper says is air poluution is bad for you. We say NSS. However is it the air pollution that is the issue or is it something that is more causal, but relates to…
M&M: Merck, Mayo Clinic team up to use AI to speed drug development in MS
Merck and Mayo Clinic have launched a research collaboration to use artificial intelligence (AI) and large-scale clinical data to accelerate drug discovery and development, with an initial focus on diseases with high unmet needs, including multiple sclerosis (MS). The partnership will combine Mayo’s extensive clinical and genomic datasets with Merck’s AI-enabled research technologies. The Merck…
Connection and Compassion: My MS Journey
By Dr. Eva Jackson Seeking Answers and Facing Uncertainty For many years, my health declined, and I found myself searching desperately for answers. Ireached out to my healthcare team, at times pleading for their help to uncover what was causingmy … Continue reading → Source: blog.mymsaa.org
Fundació GAEM, entitat beneficiària de la Campanya Solidària d’Audax Renovables
Des de la Fundació GAEM volem compartir una bona notícia: hem estat una de les entitats beneficiàries de la Campanya Solidària impulsada per Audax Renovables, rebent una aportació de 1.000 euros per contribuir a la nostra tasca de suport a la recerca biomèdica en esclerosi múltiple i neuromielitis òptica. La Campanya Solidària d’Audax Renovables és…
Childhood bacteria..was does it tell us about the cause of MS.
Tweet mmmmM…my favourite subject….Yep my Bad…I don’t know the back end of a flagelleum from the front end…So I will do like every respecting cheat and use AI rather than reading and ask it to tell me what the important bacteria in MS are. Here is the answer (from Google) “Multiple sclerosis (MS) is associated…